Sutro Biopharma (STRO) Debt Ratio (2017 - 2023)

Sutro Biopharma has disclosed Debt Ratio across 7 years of filings, most recently posting 0.01 for Q4 2023.

• Debt Ratio for Q4 2023 came in at 0.01, down 78.42% year-over-year; the trailing twelve-month figure through Dec 2023 was 0.01 (down 78.42% YoY), and the FY2023 annual result was 0.01, down 78.42% from the prior year.
• Debt Ratio came in at 0.01 for Q4 2023 at Sutro Biopharma, down from 0.02 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.16 in Q1 2020 to a low of 0.01 in Q4 2023.
• The 5-year median for Debt Ratio is 0.07 (2019), against an average of 0.06.
• Across the five-year window, Debt Ratio jumped 122.78% in 2020 and sank 78.42% in 2023, its largest moves.
• Sutro Biopharma's Debt Ratio stood at 0.06 in 2019, then declined by 1.39% to 0.06 in 2020, then advanced by 18.11% to 0.07 in 2021, then tumbled by 45.64% to 0.04 in 2022, then plunged by 78.42% to 0.01 in 2023.
• The last three Debt Ratio figures came in at 0.01 (Q4 2023), 0.02 (Q3 2023), and 0.02 (Q2 2023), per Business Quant data.